Details of the Drug
General Information of Drug (ID: DM8KMEG)
Drug Name |
6-Methyl-2-p-tolyl-chromen-4-one
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
88952-74-3; CHEMBL133226; 6-methyl-2-(4-methylphenyl)chromen-4-one; 6-methyl-2-(4-methylphenyl)-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 6-methyl-2-(4-methylphenyl)-; 6-Methyl-2-p-tolyl-chromen-4-one; ACMC-20lfbb; AC1LFDMB; 4',6-Dimethylflavone; BAS 01121723; Oprea1_016511; Oprea1_052018; SCHEMBL10024074; CTK3A4544; DTXSID70354567; MolPort-000-450-864; ZINC265995; STK888587; AKOS000603226; MCULE-9170697941; NCGC00320777-01; 6-methyl-2-(p-tolyl)-4H-chromen-4-one; ST45177106; AB00086662-03; AB00086662-01
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 250.29 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||